Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4933]

WCLC 2021: Durvalumab and tremelimumab with chemo improved PFS and OS in 1st-line stage IV NSCLC vs chemo

WCLC 2021: Durvalumab and tremelimumab with chemo improved PFS and OS in 1st-line stage IV NSCLC vs chemo

Oncology research rebounds from pandemic low, but shows cancer patients need special attention after COVID 19 recovery

Oncology research rebounds from pandemic low, but shows cancer patients need special attention after COVID 19...

KRAS G12C inhibitor sotorasib receives conditional marketing authorisation by MHRA for use in Great Britain

KRAS G12C inhibitor sotorasib receives conditional marketing authorisation by MHRA for use in Great Britain

New insights about melanocytes could lead to more targeted melanoma treatments

New insights about melanocytes could lead to more targeted melanoma treatments

Six-month efficacy of Pfizer/BioNTech COVID-19 vaccine in patients with solid tumours similar to general population

Six-month efficacy of Pfizer/BioNTech COVID-19 vaccine in patients with solid tumours similar to general population

New resource to advance genomics-driven precision medicine

New resource to advance genomics-driven precision medicine

Research proves feasibility of new cancer treatment approach

Research proves feasibility of new cancer treatment approach

Chemotherapy plus immunotherapy before surgery is beneficial for invasive bladder cancer outcomes

Chemotherapy plus immunotherapy before surgery is beneficial for invasive bladder cancer outcomes

When less is more: A modified chemotherapy regimen for a rare type of lymphoma

When less is more: A modified chemotherapy regimen for a rare type of lymphoma

Dual-action breast cancer compounds aim to overcome common drug-resistance issues

Dual-action breast cancer compounds aim to overcome common drug-resistance issues

More from ecancer